Chimin Health Management Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Jimin Health Management Co., Ltd. (hereinafter referred to as the "Company") is a modern pharmaceutical enterprise founded in 1996, with a registered capital of 477.04 million yuan. It is a key backbone enterprise in the pharmaceutical industry in Zhejiang Province and a national high-tech enterprise. The company was listed on the Shanghai Stock Exchange in February 2015 (603222. SH). The company is located in the Zhejiang Huangyan High tech Development Park, covering an area of nearly 400 acres and employing a total of over 2000 people. Since its listing, the company has actively laid out the "Big Health Strategy". Covering three major sectors of medical and health services, medical devices, and chemical pharmaceuticals, we have preliminarily constructed a strategic pattern of "one main body, two wings" led by medical devices and coordinated development of medical services and chemical pharmaceuticals. Medical devices are the core business sector of Jimin Health, including safety injection puncture device series products, pre filled catheter irrigator series products, in vitro diagnostic series products, and blood dialysis concentrate series products. The safety injection puncture device series products are in a leading position both internationally and domestically. The company has a history of more than 30 years in the injection puncture equipment business and is a leading enterprise in the segmented field of safety syringes in China. Its main products include safety syringes, safety injection needles, sterile syringes, infusion sets, and other products. The company's new product, the pre filled catheter irrigator, is a clinical application product that combines medicine and machinery. This product is mainly used in the maintenance of vascular access devices such as PICC (central venous catheterization through peripheral vein puncture) and venous indwelling needles. It has the advantages of simple operation, wide application range, reduced multiple material consumption, reduced hospital infection risk, reduced needle puncture, avoided medication errors, improved safety, improved workflow and efficiency, and has gradually become an excellent substitute for traditional saline, heparin diluent and other flushing and sealing fluids. The company's blood dialysis concentrate series products adopt ultra pure water production processes that far exceed the technical indicators of dialysis water, C+A cleanliness production environment, and automated production equipment, effectively ensuring product quality. Spain's wholly-owned subsidiary, LINEAR, has seven major product lines including various diagnostic reagents, laboratory instruments, and in vitro diagnostic medical products. Its core products, FOB fecal occult blood automatic immune monitoring and Helicobacter pylori detection kits, have strong market competitiveness. There are two comprehensive hospitals in the medical and health service sector (Boao International Hospital and Ezhou Second Hospital), and they have collaborated with multiple hospitals in blood dialysis business. The company will continue to focus on comprehensive and specialized (tumor, kidney disease, etc.) hospitals for layout, committed to building the company into a big health industry group. There are nearly 40 types of infusion products in the chemical pharmaceutical sector, including balanced, nutritional, therapeutic infusion, and topical irritants. At present, the company has three major production bases in Zhejiang, Shanghai, and Spain, with six wholly-owned or controlling subsidiaries: Hainan Jimin Boao International Hospital Co., Ltd., Ezhou Second Hospital Co., Ltd., Linya Chemical Co., Ltd., Jumin Biotechnology Co., Ltd., Zhejiang Jimin Tang Pharmaceutical Trading Co., Ltd., and Taizhou Jurui Plastic Technology Co., Ltd. |
| Headquarter | Taizhou |
| Establish Date | 12/24/1996 |
| Listed Code | 603222.SH |
| Listed Date | 2/17/2015 |
| Chairman | Lisa Li. |
| CEO | Tian Yunfei. |
| Website | www.chimin.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
